CY1116774T1 - Συνθεση η οποια περιεχει lip2a leishmania - Google Patents

Συνθεση η οποια περιεχει lip2a leishmania

Info

Publication number
CY1116774T1
CY1116774T1 CY20151100892T CY151100892T CY1116774T1 CY 1116774 T1 CY1116774 T1 CY 1116774T1 CY 20151100892 T CY20151100892 T CY 20151100892T CY 151100892 T CY151100892 T CY 151100892T CY 1116774 T1 CY1116774 T1 CY 1116774T1
Authority
CY
Cyprus
Prior art keywords
lip2a
leishmania
composition containing
composition
antigen
Prior art date
Application number
CY20151100892T
Other languages
English (en)
Inventor
Alvarez Manuel Soto
Bedate Carlos Alonso
Rolania José Maria Requena
Original Assignee
Laboratorios Leti S.L. Sociedad Unipersonal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Leti S.L. Sociedad Unipersonal filed Critical Laboratorios Leti S.L. Sociedad Unipersonal
Publication of CY1116774T1 publication Critical patent/CY1116774T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Σύνθεση, η οποία περιέχει Lip2A Leishmania από αλληλουχία DNA που περιλαμβάνει: α) την αλληλουχία νουκλεοτιδίων 778-1231 από τη SEQ ID ΝO1, β) ή αλληλουχία νουκλεοτιδίων που είναι σε θέση να υβριδίζεται με την αλληλουχία α) κάτω από μέτριες μη αυστηρές συνθήκες. Αυτή η σύνθεση χρησιμοποιείται για την επαγωγή σε ανοσοποιημένα ζώα ή κυτταρικές ομάδες, άνοσης απόκρισης έναντι αντιγόνου.
CY20151100892T 2000-04-17 2015-10-06 Συνθεση η οποια περιεχει lip2a leishmania CY1116774T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000999A ES2169995B1 (es) 2000-04-17 2000-04-17 Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
EP01971447.6A EP1279679B1 (en) 2000-04-17 2001-04-11 Composition containing leishmania lip2a

Publications (1)

Publication Number Publication Date
CY1116774T1 true CY1116774T1 (el) 2017-03-15

Family

ID=8493222

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100892T CY1116774T1 (el) 2000-04-17 2015-10-06 Συνθεση η οποια περιεχει lip2a leishmania

Country Status (8)

Country Link
US (2) US20030157125A1 (el)
EP (1) EP1279679B1 (el)
AU (1) AU9517501A (el)
CY (1) CY1116774T1 (el)
DK (1) DK1279679T3 (el)
ES (2) ES2169995B1 (el)
PT (1) PT1279679E (el)
WO (1) WO2001081388A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863272B1 (fr) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
FR2881752B1 (fr) * 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et Moyens pour l'obtention de promastigotes de leishmanies avirulents, promastigotes obtenus et leurs applications
JP2011509968A (ja) * 2008-01-18 2011-03-31 ラボラトリオス レティ、エセ．エレ．ウニペルソナル リボソームタンパク質抽出物（ＲＰＥ）及び場合によってＴｈ１促進アジュバントを含むワクチン
AU2009273128A1 (en) 2008-07-25 2010-03-11 All India Institute Of Medical Science Constructing a DNA chimera for vaccine development against Leishmaniasis and tuberculosis
RU2558233C2 (ru) 2009-07-13 2015-07-27 Лабораториос Лети, С.Л. Диагностика паразитарного заболевания, такого как лейшманиоз, с использованием экстракта рибосомальных белков (rpe)
WO2015001383A1 (en) * 2013-07-02 2015-01-08 Institut De Recherche Pour Le Developpement Peptides and methods for the detection of leishmaniasis
US10973897B2 (en) * 2016-04-14 2021-04-13 Peptcell Limited Chagas antigens and antibodies and compositions, methods and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133236B1 (es) * 1997-06-27 2000-04-16 Leti Lab Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.
US6525186B2 (en) * 1998-12-23 2003-02-25 C.B.F. Leti S.A. Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained
US6458359B1 (en) * 1998-12-23 2002-10-01 C.B.F. Leti S.A. Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans
ES2326174T3 (es) * 1998-12-23 2009-10-02 Laboratorios Leti, S.L. Gen quimerico que codifica los determinantes antigenicos de cuatro proteinas de l. infantum.

Also Published As

Publication number Publication date
ES2169995A1 (es) 2002-07-16
ES2546301T3 (es) 2015-09-22
PT1279679E (pt) 2015-12-24
US20060127418A1 (en) 2006-06-15
AU9517501A (en) 2001-11-07
US20030157125A1 (en) 2003-08-21
EP1279679A1 (en) 2003-01-29
EP1279679B1 (en) 2015-07-08
WO2001081388A1 (es) 2001-11-01
DK1279679T3 (en) 2015-08-24
ES2169995B1 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
CY1116774T1 (el) Συνθεση η οποια περιεχει lip2a leishmania
CY1119650T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1112985T1 (el) Χρηση αλληλουχιων dνα τριπλου ελικα για τη μεταφορα νουκλεοτιδικων αλληλουχιων
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1105919T1 (el) Αντιμικροβιακα πολυπεπτιδια απο pseudoplectania nigrella
CY1120265T1 (el) Μεθοδος παραγωγης αντισωματος με μεταβλητη περιοχη ανθρωπου και με σταθερη περιοχη τρωκτικου
CY1108013T1 (el) Dna εμβολια για τους ιππους που περιεχουν ανοσοενισχυτικους παραγοντες με πολυμερη του ακρυλικου ή μεθακρυλικου οξεος ή του εμα(r)
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
NO20030621L (no) Anti-dual integrinantistoffer, sammensetninger, fremgangsmater og anvendelser
CY1105282T1 (el) Διαγνωση της κοιλιοκακης με τη χρηση ενος επιτοπιου της γλιαδινης
DK1221955T3 (da) Immunstimulerende nukleinsyre
TR200401186T4 (tr) Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları.
DE69636288D1 (de) Samenstrenung resistenz
DE69535125D1 (de) Impstoff gegen felines immunodefizienz-virus
DE60021497D1 (de) Menschliche, für zyklische Nukleotide spezifische Phosphodiesterase
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
CY1105109T1 (el) Διαδικασια για την παρασκευη μικρου μοριακου βαρους πολυαιθυλενιμινης
BR0114199A (pt) Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas
CY1105439T1 (el) Κυτταρα, μεθοδοι καλλιεργειας και η χρηση τους στη θepαπεια με αυτολογη μεταμοσχευση
DE60129028D1 (de) Zelluläre arrays zur identifizierung von veränderter genexpression
NO20000097L (no) Isolerte dendrittcellemembranproteingener
CY1115543T1 (el) Dνα ανασυνδυασμος ειδικης ακολουθιας σε ευκαρυωτικα κυτταρα
TR200001046T2 (tr) Homolog rekombinasyonda pozitif-negatif seçimi.
CY1108619T1 (el) Πρωτεϊνη σπονδυλωτων patched-2